Presentation is loading. Please wait.

Presentation is loading. Please wait.

ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60.

Similar presentations


Presentation on theme: "ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60."— Presentation transcript:

1 ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60

2 ACE inhibitors, ARBs and Statins in COPD: Demographics of Cases and Controls in the High-Risk Cohort G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60

3 ACE inhibitors, ARBs and Statins in COPD: Demographics of Cases and Controls in the Low-Risk Cohort G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60

4 ACE inhibitors, ARBs and Statins in COPD: Unadjusted Risk Ratios and 95% Confidence Intervals in the High- and Low-Risk COPD Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60

5 ACE inhibitors, ARBs and Statins in COPD: Fully adjusted risk ratios and 95% Confidence Intervals in the High-Risk COPD Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60

6 ACE inhibitors, ARBs and Statins in COPD: Fully adjusted risk ratios and 95% Confidence Intervals in the Low-Risk COPD Cohorts


Download ppt "ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:2554-60."

Similar presentations


Ads by Google